Business
Single-shot Johnson & Johnson vaccine 66 per cent effective against COVID-19, study shows – The Age
The company says its vaccine is 72 per cent effective in preventing COVID-19 in the US but a lower rate of 66 per cent was observed globally in the large trial…
J&J plans to seek emergency use authorisation in the US within a week. It expects to supply 100 million doses to the US by June and a billion doses globally by years end but declined to say how much could be ready if the Food and Drug Administration gives the green light.
Defeating the scourge that has killed more than 2 million people worldwide will require vaccinating billions. The shots being rolled out in different countries so far all require two doses a few weeks apart for full protection….
-
General23 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
General9 hours agoLiberals go back to basics after crawling to year’s end
-
Business15 hours ago3 of the best ASX ETFs to build significant wealth
-
General12 hours agoProtecting victims of explicit AI content online